Page 28 - Webcast Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Reached Agreement with U.S. FDA on Design of SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Resumed Recruitment into SHIELD II Phase 3 Trial in Late June 2023 Total of 20 centers in U.S., Europe and Israel Expected to be Opened by End of Current Quarter Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage bio

SCOTTSDALE, Ariz., Aug. 09, 2023 -- LifeStance Health Group, Inc. , one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter...

Quarterly revenue of $0.6 million following successful achievement of milestones on autonomous vehicle development contracts MENLO PARK, Calif., August 9, 2023 - Cyngn Inc. , a...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with...

/PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (NASDAQ: CYN), a developer of AI-powered autonomous driving software solutions for industrial...